Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand

S Claflin, JA Campbell, R Norman, DF Mason… - The European Journal of …, 2023 - Springer
Background Health state utilities (HSU) are a health-related quality-of-life (HRQoL) input for
cost-utility analyses used for resource allocation decisions, including medication …

Measuring the cost-effectiveness of treatments for people with multiple sclerosis: beyond quality-adjusted life-years

A Hawton, E Goodwin, K Boddy… - Multiple Sclerosis …, 2022 - journals.sagepub.com
Background: It is a familiar story. A promising multiple sclerosis (MS) treatment clears the
three regulatory hurdles of safety, quality and efficacy, only to fall at the fourth: cost …

[HTML][HTML] What difference does it make? A comparison of health state preferences elicited from the general population and from people with multiple sclerosis

E Goodwin, C Green, A Hawton - Value in Health, 2020 - Elsevier
Background A major debate in the quality-adjusted life-year (QALY) literature concerns
whose preferences should be used to estimate health state values (HSVs) and to calculate …

The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D

A Hawton, C Green, CJ Telford… - Multiple Sclerosis …, 2012 - journals.sagepub.com
Background: Walking impairment has a major influence on the quality of life of people with
multiple sclerosis (MS). The Multiple Sclerosis Walking Scale (MSWS-12) assesses the …

Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control …

MF Sidovar, BL Limone, CI Coleman - Patient related outcome …, 2016 - Taylor & Francis
Background Mapping of patient-reported outcomes to the five-dimension EuroQol (EQ-5D)
health index is increasingly being used for understanding the relationship of outcomes to …

Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis

A Hawton, J Shearer, E Goodwin, C Green - Applied health economics and …, 2013 - Springer
Background Multiple sclerosis (MS) is a chronic neurological disorder, which can lead to a
wide range of disabling symptoms. The condition has a significant negative impact on health …

Cognitive decline may not be adequately captured in economic evaluations of multiple sclerosis: are new treatments being undervalued?

A Lloyd, H Schofield, N Adlard - Current Medical Research and …, 2020 - Taylor & Francis
Cognitive impairment interferes with a patientLs attention span, decision-making ability,
understanding and concentration, impacting on their day-to-day life 1. Nearly half of patients …

The external validity of mapping MSIS-29 on EQ-5D among individuals with multiple sclerosis in Sweden

O Ernstsson, P Tinghög, K Alexanderson… - MDM Policy & …, 2017 - journals.sagepub.com
Background: Mapping can be performed to predict utility values from condition-specific
measures when preference-based measures are absent. A previously developed algorithm …

Estimating the disutility of relapse in relapsing–remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF …

H Ahmad, JA Campbell, I van der Mei, BV Taylor… - Quality of Life …, 2023 - Springer
Background and aims Relapses are an important clinical feature of multiple sclerosis (MS)
that result in temporary negative changes in quality of life (QoL), measured by health state …

[HTML][HTML] Estimating health state utility values for comorbid health conditions using SF-6D data

R Ara, J Brazier - Value in Health, 2011 - Elsevier
Introduction When health state utility values for comorbid health conditions are not available,
data from cohorts with single conditions are used to estimate scores. The methods used can …